Humana Inc.
$304.10-2.08%($-6.45)
TickerSpark Score
67/100
84
Valuation
55
Profitability
50
Growth
64
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUM research report →
52-Week Range92% of range
Low $163.11
Current $304.10
High $315.60
Companywww.humana.com
Humana Inc. , together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services.
- CEO
- James A. Rechtin
- IPO
- 1981
- Employees
- 65,680
- HQ
- Louisville, KY, US
Price Chart
+19.11% · this period
Valuation
- Market Cap
- $36.51B
- P/E
- 32.38
- P/S
- 0.27
- P/B
- 1.97
- EV/EBITDA
- 15.98
- Div Yield
- 1.16%
Profitability
- Gross Margin
- 14.01%
- Op Margin
- 1.01%
- Net Margin
- 0.82%
- ROE
- 6.19%
- ROIC
- 3.23%
Growth & Income
- Revenue
- $129.66B · 10.06%
- Net Income
- $1.19B · -1.57%
- EPS
- $9.87 · -1.40%
- Op Income
- $1.45B
- FCF YoY
- -84.32%
Performance & Tape
- 52W High
- $315.60
- 52W Low
- $163.11
- 50D MA
- $212.56
- 200D MA
- $243.03
- Beta
- 0.68
- Avg Volume
- 1.83M
Get TickerSpark's AI analysis on HUM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Mellet Celeste | other | 15,387 |
| May 1, 26 | Mehta Japan | other | 9,448 |
| May 1, 26 | Dintenfass David | other | 11,273 |
| May 1, 26 | Rechtin James A. | other | 35,633 |
| May 1, 26 | O'Hara Michelle A. | other | 10,485 |
| May 1, 26 | Field Robert Stuart | other | 852 |
| May 1, 26 | Ventura Joseph C | other | 10,318 |
| May 1, 26 | Shetty Sanjay K | other | 9,945 |
| May 1, 26 | Martin Aaron | other | 8,206 |
| Apr 16, 26 | Field Robert Stuart | other | 0 |
Our HUM Coverage
We haven't published any research on HUM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HUM Report →